Cramer says the growing popularity of weight loss drugs brings new investing opportunities

CNBC's Jim Cramer on Monday highlighted sectors that may benefit from the increased usage of GLP-1 drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.